FLGT
Fulgent Genetics, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -15.0% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 250 | $5,324 | n/a | n/a |
| Q2 2026 | 61 | -5 | 10.73M | $220.18M | +4 | −10 |
| Q1 2026 | 69 | 0 | 11.71M | $186.24M | +4 | −4 |
| Q4 2025 | 69 | +1 | 14.16M | $372.03M | +1 | n/a |
| Q3 2025 | 14 | 0 | 9.19M | $207.61M | n/a | n/a |
| Q2 2025 | 11 | -2 | 7.55M | $150.07M | n/a | −2 |
| Q1 2025 | 10 | +1 | 3.99M | $67.47M | +1 | n/a |
| Q4 2024 | 9 | -1 | 3.49M | $64.46M | n/a | −1 |
| Q3 2024 | 9 | +1 | 2.57M | $55.79M | +2 | −1 |
| Q2 2024 | 8 | n/a | 1.93M | $37.93M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dimensional Fund Advisors Lp | 671.66K | -24.4% | $10.68M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | Ameriprise Financial Inc | 563.38K | +12.8% | $8.96M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | State Street Global Advisors ✦ (passive) | 529.40K | +7.2% | $8.42M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 486.77K | -30.6% | $7.74M | 0.0% | ▼ Trim | 8 | SEC ↗ |
| 5 | JPMorgan Chase ✦ | 460.36K | +84.0% | $7.20M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 6 | Charles Schwab Investment… | 354.18K | -12.1% | $5.63M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Deutsche Bank Ag\ | 325.45K | -25.9% | $5.17M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Goldman Sachs Group ✦ | 311.42K | -10.7% | $4.95M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 9 | Morgan Stanley ✦ | 192.40K | -39.0% | $3.06M | 0.0% | ▼ Trim | 3 | SEC ↗ ×8 |
| 10 | Northern Trust Corp | 182.11K | +1.8% | $2.90M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 11 | Wells Fargo & Company/Mn | 147.13K | +21.8% | $2.34M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 12 | Barclays Plc | 141.01K | -18.1% | $2.24M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 13 | Bank Of America Corp /De/ | 120.58K | -21.1% | $1.92M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 14 | UBS AM, a distinct business unit of… | 101.30K | +1.0% | $1.61M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 15 | Sei Investments Co | 74.23K | -0.4% | $1.18M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 16 | Hsbc Holdings Plc | 65.17K | -37.4% | $1.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Tudor Investment Corp Et Al | 64.09K | -44.8% | $1.02M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Invesco Ltd. | 56.98K | -8.1% | $905,983 | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 19 | American Century Companies Inc | 53.94K | -1.4% | $857,662 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 26.67K | +19.0% | $425,000 | 0.0% | ▲ Add | 8 | SEC ↗ |
| 21 | Legal & General Group Plc | 18.81K | -10.2% | $299,031 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 22 | Renaissance Technologies ✦ | 18.00K | -78.3% | $286,200 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | Citigroup Inc | 17.41K | +2825.2% | $276,740 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 24 | Franklin Resources Inc | 13.78K | -0.7% | $219,055 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 25 | Mackenzie Financial Corp | 10.73K | -10.8% | $170,607 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | New York State Common Retirement… | 8.17K | 0.0% | $129,951 | 0.0% | Held | 2 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 790 | -80.2% | $12,563 | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 28 | Pnc Financial Services Group, Inc. | 720 | -48.4% | $11,448 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 29 | Royal Bank Of Canada | 728 | -44.0% | $11,000 | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 30 | Jones Financial Companies Lllp | 289 | -34.5% | $4,506 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 31 | Fifth Third Bancorp | 240 | New | $3,817 | 0.0% | New | 1 | SEC ↗ |
| 32 | National Bank Of Canada /Fi/ | 188 | +5.6% | $2,989 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 33 | Us Bancorp \De\ | 84 | -83.8% | $1,336 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Fifth Third Bancorp | $3,817 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 156 holders, 16.99M shares, $249.23M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 1.67K sh · $32,885
Officer · 2.13K sh · $41,809
Officer · 939 sh · $18,691
Officer · 1.19K sh · $23,747
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
32.3% of class · View original SEC filing ↗